DOI 10.1007/s00421-007-0557-x
ORIGINAL ARTICLE
Introduction
Multiple studies demonstrate the ergogenic ability of caffeine (CAF) for endurance exercise. In a study by Costill
et al. (1978), nine men and women exercised on a cycle
ergometer to exhaustion at 80% maximal oxygen uptake
_ 2 max ). Exercise time was 20% longer with coffee
(VO
(caffeine dose = 330 mg) vs. placebo. Compared to placebo, total work during 2 h of cycling was 7.4% higher
with two 250 mg doses of caffeine (Ivy et al. 1979).
Therefore, data from several reports suggest that acute
caffeine ingestion enhances endurance performance.
However, the potential of caffeine to enhance dynamic
muscular strength and endurance has received less attention. In a study by Jacobson et al. (1992), a 7 mg/kg
caffeine dose significantly enhanced muscular strength
measured with isokinetic dynamometry. Yet, no effect of a
5 mg/kg dose of caffeine in response to isokinetic exercise
was revealed in another study (Bond et al. 1986). To our
knowledge, only two studies have examined the effect of
caffeine intake on resistance training performance. Compared to placebo, greater one-repetition maximum (1-RM)
bench press was demonstrated in resistance-trained men
(Beck et al. 2006) after ingestion of a caffeine-containing
supplement, yet no difference in leg press 1-RM was evident. In contrast, Jacobs et al. (2003) revealed no effect of
caffeine ingestion alone (4 mg/kg) on muscular endurance
compared to placebo, ephedrine alone, or caffeine plus
ephedrine. Data supporting the ingestion of caffeine to
augment muscular strength and endurance are rather
equivocal, so additional investigation is warranted.
123
128
The exact mechanisms by which caffeine exerts its ergogenic effects are still unresolved. It was originally believed
(Costill et al. 1978) that glycogen sparing and greater fat utilization explain the enhanced performance with caffeine,
although a recent study (Graham et al. 2000) showed an ergogenic effect of caffeine in the absence of increased lipolysis.
Caffeine ingestion has been shown to reduce the sensation of
pain induced by exercise (Motl et al. 2003), enhance excitationcontraction coupling (Lopes et al. 1983), and stimulate the
central nervous system (Graham 2001) by altering motor unit
recruitment and perceptions of fatigue via antagonism of the
adenosine receptor. Nevertheless, the goal of the present study
was not to elucidate the mechanisms of caffeines ergogenic
action, but to examine the efficacy of pre-exercise caffeine
ingestion during maximal strength and endurance testing.
The primary aims of this study were twofold: (1) to
examine the effect of acute ingestion of caffeine (6 mg/kg)
on one-repetition maximum (1-RM) performance in individuals familiar with resistance training, and (2) to examine
if muscular endurance is altered with caffeine ingestion. It
was hypothesized that compared to placebo, caffeine will
not affect 1-RM performance, yet muscular endurance will
be significantly enhanced with caffeine ingestion.
Methods
Design
Treatment order (caffeine or placebo) was randomly
assigned to participants. A double-blind crossover design
was used, as neither investigators nor participants were
aware of treatment order. Trials were separated by 1 week
to minimize subject fatigue.
Participants
Twenty-two resistance-trained men participated in the
study. They completed total-body resistance training a
minimum of 2 days per week. Women were excluded from
participation, as data (Lane et al. 1992) show that the
menstrual cycle or oral contraceptive use may alter clearance of caffeine. Demographic data are described in
Table 1. Four participants were completely nave to caffeine
intake. Participants filled out a health-history questionnaire
and provided written informed consent before participating
in the study, and all experimental procedures were approved
by the University Institutional Review Board.
Monitoring of exercise status and dietary intake
Participants completed 24 h diet and exercise recalls before
each trial, and were required to follow the same diet on the
123
Mean
Age (year)
23.4
Height (m)
1.78
SD
3.6
0.05
Range
18.029.0
1.731.88
Mass (kg)
82.5
13.6
68.0124.5
10.7
4.9
5.722.1
6.0
2.8
1.512.0
110.5
152.3
0600
4.4
2.9
07.0
Statistical analysis
Data are reported as mean SD and were analyzed using
SPSS Version 14 (Chicago, IL). Multivariate analysis of
variance (ANOVA) was used to examine differences in all
indices of muscular strength and endurance and RPE
between caffeine and placebo. A 2 (treatment) 2 (time,
signifying pre-exercise and during the warm-up) analysis
of variance with repeated measures was used to examine
differences in cardiovascular variables (HR and systolic
BP) between the CAF and PL treatment. Tukeys post hoc
test was used to locate differences between means if a
significant F ratio was obtained. A caffeine-mediated difference in performance of 4 (bench press) and 8% (leg
press), equal to twice the difference obtained in pilot
testing over repeated days, was denoted to be of practical
significance. With the variability in our methods, a desired
sample size of 20 and 2 was calculated post hoc for bench
press and leg press 1-RM testing. With a sample size equal
to 22, statistical power was equal to 0.06 for bench press
129
and 0.09 for leg press 1-RM, respectively, and 0.22 and
0.11 for number of repetitions of bench press and leg press
exercise at 60%1-RM. Statistical significance was established at P \ 0.05.
Results
1-RM data
Multivariate one-way ANOVA revealed no effect (Wilks
Lambda (5, 38) = 0.909, P [ 0.05) of CAF on bench press
muscular strength and endurance compared to placebo.
1-RM bench press was similar with CAF versus placebo
(Table 2). Ninety-five percent confidence intervals were
equal to 0.416.77 kg for bench press exercise. Twelve
participants bench pressed at least 3 kg more weight with
CAF, yet five lifted more weight (at least 3 kg) in the PL
trial, and in the remaining five, 1-RM was identical
between the treatments. Multivariate one-way ANOVA
revealed no effect (Wilks Lambda (5, 38) = 0.935,
P [ 0.05) of CAF on leg press muscular strength and
endurance compared to placebo. Ninety-five percent confidence intervals were equal to 4.9674.48 kg for the leg
press. Eleven men lifted at least 10 kg more weight with
CAF, yet eight leg pressed more with PL ingestion, and
three participants revealed no difference in leg press 1-RM
between treatments.
Caffeine
Placebo
116.4 23.6
114.9 22.8
19.9 4.3
18.4 4.0
69.9 14.3
1,369.7 383.1
68.9 13.3
1,226.2 357.3
410.6 92.4
394.8 95.4
Repetitions at 60%
1-RM (reps)
23.9 13.0
22.5 11.0
Repetitions at 60%
1-RM (reps)
Weight at 60% 1-RM (kg)
Total weight lifted (kg)
247.9 57.5
238.6 55.5
5,945.9 3,275.6
5,358.0 2,148.5
123
130
Discussion
In the present study, it was hypothesized that 1-RM muscular strength would be unaffected by acute caffeine
ingestion, and a significant increase in muscular endurance
would be shown. Data support the first hypothesis, as
compared to placebo, 1-RM bench press and leg press were
unchanged with a single 6 mg/kg dose of caffeine taken
1 h before exercise. Number of repetitions at a submaximal
intensity and total weight lifted were not different
(P [ 0.05) with caffeine compared to placebo, opposing
our second hypothesis. However, the practical significance
of this finding remains unclear, given that a relatively large
increase in muscular endurance (1112%) following caffeine ingestion was statistically insignificant with our small
and non-homogenous sample of subjects. To resolve this
issue, it will be necessary to study a larger group of subjects and/or to reduce subject variability, recruiting
individuals with very similar caffeine intake, body mass,
and training status. Further investigation is warranted to
examine effects of training specificity and typical caffeine
intake on dynamic muscular strength and endurance with
acute caffeine ingestion.
To our knowledge, only two studies have examined the
effect of acute caffeine ingestion on dynamic resistance
training performance. In a study by Jacobs et al. (2003), 13
resistance-trained men completed supersets of leg press
and bench press to fatigue at 80 and 70% 1-RM after
ingesting caffeine (4 mg/kg) or placebo 90 min pre-exercise. No difference in any parameter of muscular endurance
was noted between treatments, and large variability in
responses was reported by the authors. A caffeine-containing supplement (dose = 2.4 mg/kg) taken 1 h preexercise significantly increased bench press 1-RM
(+2.1 kg) in men regularly participating in strength training
(Beck et al. 2006). However, no change (P [ 0.05) in
lower body performance (leg extension 1-RM and total
work and mean and peak power from the Wingate test) was
observed. The meaningfulness of these results can be
questioned, as the magnitude of increase in 1-RM performance reported by these authors was similar to the testretest variability of this measure in the present study. In
addition, any interaction of the supplements other ingredients (guarana, green/black tea extract, Vitamin C, and
others) on the ergogenic properties of caffeine is unknown.
Our data oppose those of Beck et al. (2006) and others
demonstrating a significant ergogenic effect of caffeine for
short-term, intense exercise. In 20 collegiate football
players completing isokinetic dynamometry, a 7 mg/kg
dose ingested 1 h pre-exercise enhanced muscular strength
and power by 511% compared to placebo (Jacobson et al.
1992). Kalmar and Cafarelli (1999) reported higher maximal voluntary contraction and greater ability to activate the
warm-up
120
110
100
90
80
70
60
50
Placebo
Caffeine
Treatment
pre-exercise
warmup
170
*
150
130
110
90
Placebo
Caffeine
Treatment
Fig. 1 Effect of acute CAF ingestion on cardiovascular responses
(*P \ 0.05 CAF vs. PL). a Heart rate response to acute CAF
ingestion. b Systolic blood pressure response to acute CAF ingestion
123
131
Conclusion
Our data do not support the ingestion of a single 6 mg/kg
dose of caffeine taken 1 h before exercise to significantly
enhance intense bench press or leg press exercise. All
123
132
parameters measured including 1-RM, number of repetitions and weight lifted at 60% 1-RM, total weight lifted,
and RPE were not significantly different between caffeine
and placebo, although muscular endurance was 1112%
higher with caffeine vs. placebo. The practical significance
of these findings may be important for the individual
exerciser, and merits further research to examine the efficacy of acute caffeine intake for dynamic muscular
strength and endurance.
Acknowledgments The authors are indebted to Mr. Gary Marx
R.Ph for preparing the caffeine and placebo capsules used in the
present study, as well as the participants for their outstanding effort in
completing the demands of this protocol. We also thank the reviewers
for valuable feedback leading to a better and more focused
manuscript.
References
Baechle TR, Earle RW (2000) Essentials of strength training and
conditioning. 2nd edn. Human Kinetics, Champaign
Beck TW, Housh TJ, Schmidt RJ, Johnson GO, Housh DJ, Coburn
JW, Malek MH (2006) The acute effects of a caffeine-containing
supplement on strength, muscular endurance, and anaerobic
capabilities. J Strength Cond Res 20(3):506510
Bond V, Gresham K, McRae J, Tearney RJ (1986) Caffeine ingestion
and isokinetic strength. Br J Sports Med 20(3):135137
Borg GAV (1982) Psychophysical bases of perceived exertion. Med
Sci Sports Exerc 14:377381
Costill DL, Dalsky GP, Fink WJ (1978) Effects of caffeine ingestion
on metabolism and exercise performance. Med Sci Sports
10(3):155158
Doherty M, Smith PM (2005) Effects of caffeine ingestion on rating
of perceived exertion during and after exercise: a meta-analysis.
Scand J Med Sci Sports 15:6978
Graham TE (2001) Caffeine and exercise: metabolism, endurance,
and performance. Sports Med 31(11):785807
Graham TE, Spriet LL (1995) Metabolic, catecholamine, and exercise
performance responses to various doses of caffeine. J Appl
Physiol 78:867874
Graham TE, Helge JW, MacLean DA, Kiens B, Richter EA (2000)
Caffeine ingestion does not alter carbohydrate or fat metabolism
in human skeletal muscle during exercise. J Physiol (Lond)
529:837847
123
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.